76328-92-2

Upstream product

• 92596-17-3 O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-(1->3)-O-(2-acetamido-4,6-di-O-acetyl-2-deoxy-β-D-glucopyranosyl)-(1->3)-2,4,6-tri-O-acetyl-α-D-galactopyranosyl bromide 
• 148766-03-4 3-O-<2-acetamido-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranosyl>-1,2,4,6-tetra-O-acetyl-α-D-galactopyranose 
• 92596-15-1 methyl 3-O-<2-acetamido-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranosyl>-2,4,6-tri-O-acetyl-β-D-galactopyranoside 
• 92596-18-4 p-nitrophenyl 3-O-<2-acetamido-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranosyl>-2,4,6-tri-O-acetyl-β-D-galactopyranoside 

Relevant academic research and scientific papers

A convenient synthesis of lacto-N-biose I [β-D-Galp-(1 → 3)-β-D-GlcpNAc] linkd oligosaccharides from phenyl O-(tetra-O-acetyl-β-D-galactopyranosyl)-(1 → 3)-4,6-di-O-acetyl-2-deoxy-2-phthalmido-1-thio-β-D-glucopyranoside

The synthesis of two tetrasaccharides and one trisaccharide containing lacto-N-biose I (β-D-Galp(1 → 3)-β-D-GlcpNAc) as their terminal unit was accomplished through development and utilization of a key glycosyl donor, namely, phenyl O-(2,3,4,6-tetra-O-ace